Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Br J Cancer (in press)
DOI 10.1038/s41416-025-03054-w, PubMed 40382522
A man in his fifties with lymphoma, vomiting and diarrhoea
Tidsskr Nor Laegeforen, 145 (6)
DOI 10.4045/tidsskr.24.0605, PubMed 40366042
Biomarker-adapted treatment in high-risk large B-cell lymphoma
Hemasphere, 9 (5), e70139
DOI 10.1002/hem3.70139, PubMed 40357216